A fatal case of gastric mucormycosis: a case report
DOI:
https://doi.org/10.18203/2349-3933.ijam20263725Keywords:
Mucormycosis, Necrotic gastric ulcer, Posaconazole, Chronic kidney diseaseAbstract
Mucormycosis is an invasive infection caused by the fungi of the order Mucorales. The members of the family Mucoraceae most commonly isolated are Rhizopus and the second most common genus is Mucor. It typically affects immunocompromised individuals. Common presenting symptoms are abdominal pain, hematemesis and melena. The infection pathway is airborne through skin or ingestion of the sporangiospores. Primary gastrointestinal mucormycosis is a rare disease with a high mortality rate. We report a case of mucormycosis associated necrotic gastric ulcer with a fatal outcome. A 47-year-old female with history of chronic kidney disease presented with acute gastrointestinal symptoms. An endoscopy was performed and diagnosis of peptic ulcer disease in the setting of hemodialysis was made. Histopathology revealed mucormycosis and she was started on posaconazole. The patient was stabilized and discharged however failed to comply to antifungal treatment; resulting in a fatal outcome. Recognizing gastric mucormycosis early with timely treatment is essential for a good outcome.
References
Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18(3):556-69.
Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634-53.
Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54 Suppl 1:S23-34.
Didehdar M, Chegini Z, Moradabadi A, Anoushirvani AA, Tabaeian SP, Yousefimashouf M, et al. Gastrointestinal mucormycosis: a periodic systematic review of case reports from 2015 to 2021. Microb Pathog. 2022;163:105388.
Huang H, Xie L, Zheng Z, Yu H, Tu L, Cui C, Yu J. Mucormycosis-induced upper gastrointestinal ulcer perforation in immunocompetent patients: a report of two cases. BMC Gastroenterol. 2021;21(1):311.
Kaur H, Ghosh A, Rudramurthy SM, Chakrabarti A. Gastrointestinal mucormycosis in apparently immunocompetent hosts—a review. Mycoses. 2018;61(12):898-908.
Addasi Y, Nguyen AH, Sabri A, Ahmad F, Rangray R, Velagapudi M. Gastrointestinal mucormycosis: a clinical review. Gastroenterology Res. 2023;16(5):249-53.
Naqvi HA, Nadeem Yousaf M, Chaudhary FS, Mills L. Gastric mucormycosis: an infection of fungal invasion into the gastric mucosa in immunocompromised patients. Case Rep Gastrointest Med. 2020;2020:8876125.
Sree Lakshmi I, Kumari BS, Jyothi C, Devojee M, Padma Malini K, Sunethri P, et al. Histopathological study of mucormycosis in post COVID-19 patients and factors affecting it in a tertiary care hospital. Int J Surg Pathol. 2023;31(1):56-63.
Park JW, Chung JS, Lee S, Shin HJ. Neutropenic enterocolitis due to mucormycosis in a patient with myelodysplastic syndrome. Infect Chemother. 2020;52(1):98-104.
Alfano G, Fontana F, Francesca D, Assirati G, Magistri P, Tarantino G, et al. Gastric mucormycosis in a liver and kidney transplant recipient: case report and concise review of literature. Transplant Proc. 2018;50(3):905-9.
Tathe SP, Dani AA, Chawhan SM, Meshram SA, Randale AA, Raut WK. Gastric mucormycosis: diagnosis by imprint cytology. Diagn Cytopathol. 2016;44(10):820-2.
Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405-21.
Walsh TJ, Goodman JL, Pappas P, Bekersky I, Buell DN, Roden M, et al. Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother. 2001;45(12):3487-96.
Kato H, Hagihara M, Yamagishi Y, Shibata Y, Kato Y, Furui T, et al. The evaluation of frequency of nephrotoxicity caused by liposomal amphotericin B. J Infect Chemother. 2018;24(9):725-8.
van Burik JAH, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis. 2006;42(7):e61-5.
Gunathilaka SS, Keragala RK, Gunathilaka KM, Wickramage S, Bandara SR, Senevirathne IS, et al. Use of isavuconazole in mucormycosis: a systematic review. BMC Infect Dis. 2025;25(1):25.
Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014;20 Suppl 3:5-26.
Thomson SR, Bade PG, Taams M, Chrystal V. Gastrointestinal mucormycosis. Br J Surg. 1991;78(8):952-4.
de Oliveira JEP, Milech A. A fatal case of gastric mucormycosis and diabetic ketoacidosis. Endocr Pract. 2002;8(1):44-6.
Debata PK, Panda SK, Dash A, Mohanty R, Mallick BN, Tadu D, et al. An unusual presentation of colonic mucormycosis mimicking carcinoma colon—a surgeon’s perspective. Int J Surg Case Rep. 2015;10:248-51.
Sugar AM. Mucormycosis. Clin Infect Dis. 1992;14 Suppl 1:S126-9.
Ibrahim AS, Spellberg B, Avanessian V, Fu Y, Edwards JE. Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro. Infect Immun. 2005;73(2):778-83.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Karan Kaura, Arundhati Diwan, Supriya Barsode, Komal Singh, Kunda Jagdale
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
